Evidence map›Paper›PMID 41970846›Full record

ArticleACS omega2026

Development and Validation of an Isocratic HPLC Method for the Simultaneous Determination of Avobenzone and Tris-Biphenyl Triazine.

Júlio A Miranda, Yasmin F da Cruz, Éverton N Alencar, Wógenes N Oliveira, Daniel Cristian F Soares, Maureen D Donovan, E Sócrates T Egito

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Júlio A MirandaGraduate Program in Health Sciences, Federal University of Rio Grande do Norte, UFRN, Natal 59012-570, RN, Brazil.
Yasmin F da CruzGraduate Program in Health Sciences, Federal University of Rio Grande do Norte, UFRN, Natal 59012-570, RN, Brazil.
Éverton N AlencarLaboratory of Micro and Nanostructured Systems, College of Pharmaceutical Sciences, Food and Nutrition, Federal University of Mato Grosso do Sul (UFMS), Campo Grande 79070-900, MS, Brazil.ORCID https://orcid.org/0000-0002-6148-6804
Wógenes N OliveiraGraduate Program in Health Sciences, Federal University of Rio Grande do Norte, UFRN, Natal 59012-570, RN, Brazil.
Daniel Cristian F SoaresLaboratory of Bioengineering, Pure and Applied Institute, Federal University of Itajuba, Itabira 35903-087, MG, Brazil.
Maureen D DonovanDepartment of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, Iowa 52242, United States.
E Sócrates T EgitoGraduate Program in Health Sciences, Federal University of Rio Grande do Norte, UFRN, Natal 59012-570, RN, Brazil.ORCID https://orcid.org/0000-0002-2180-3991

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Avonenzone (AVO) and tris-biphenyl triazine (TBPT) are ultraviolet (UV) filters commonly used in sunscreen formulations. Their combination enables broad-spectrum photoprotection and improved photostability. Despite their widespread and emerging use, the

Identifiers

PMID41970846
PMCPMC13063171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.